Results 51 - 75 from 104 for "pharma"
-
Terapia, First Profit Decline In Six Years
04.24.2015
Cluj-based Terapia, the largest local drug producer, posted net profit worth 86 million lei (EUR19 million) last year, down 21% against 2013. This is the first decline the drug maker has witnessed in more
-
A&D Pharma Shareholders Stick Low-Cost Brand Punkt On Part Of Bucharest Sensiblu Pharmacies
04.08.2015
A&D Pharma, the largest group in Romania’s drug industry, has reached a network of over 10 Punkt-branded pharmacies, according to data compiled by ZF, with the new network taking shape in just a few more
-
Romania, Among Top 5 Emerging Markets For New Terapia Owner Sun Pharma
03.26.2015
Sun Pharma group, founded by Dilip Shanghvi, one of India’s wealthiest businessmen, generates sales of over $100 million in Romania, the second largest market in Europe after Russia. Romania is also more
-
Pharma Producers Fired 300 People Last Year, Lowered Production For Domestic Market
01.19.2015
Producers of generic pharmaceuticals in Romania fired over 300 people last year, made no major investments, lowered production for the domestic market by around 10% and their exports stagnated due to more
-
Romania’s Drug Market Seen Growing In 2015 After Challenging 2014
01.09.2015
The drug market is likely to rise by 2-3% this year, when it may go beyond RON12 billion, according to ZF calculations based on the expectations of the main players in this industry, after a difficult more
-
Roche Romania’s Expectations For 2015
12.29.2014
Roche Romania, the largest player on the local pharmaceutical market, estimates the industry will register tepid growth, of 2-3%, in 2015. more
-
Cegedim Revises Pharma Market Forecast Considering “Harsher Cold Season”
12.09.2014
Market research company Cegedim Romania changed its outlook about the trend of the drug market in 2014, from a negative one to one of slight growth. more
-
Labormed Raises Share Capital By EUR55M, Alvogen Lux Holdings Becomes Shareholder
11.17.2014
Romanian generic drug producer Labormed Pharma will raise its share capital by EUR55 million by converting into shares part of a EUR85.28 million receivable it owes Alvogen Lux Holdings S.a.r.l., more
-
CNAS: We Need More Private Insurers To Take On The Risk
10.01.2014
There should be more companies providing medical insurance, so the healthcare sector would get more money, Vasile Ciurchea, chairman of the National Health Insurance House (CNAS) said at the ZF Pharma more
-
Romanian Pharmaceutical Market Might Fall By Up To 1.5% In 2014 – Cegedim
09.29.2014
The Romanian pharmaceutical market might fall by up to 1.5% this year, while a return to growth next year would depend on the final version of reimbursed drugs list, Petru Craciun, general manager of more
-
Romanian Pharma Industry Calls For Development Strategy
09.29.2014
Romania needs a pharmaceutical industry development strategy because the industry's contributions to the state budget are major, Antibiotice Iasi general manager Ioan Nani said Monday at the ZF Pharma more
-
Romania’s 20 Largest Pharmacy Chains Go Beyond EUR1B In Revenue In 2013
09.08.2014
The 20 largest pharmacy networks in Romania in 2013 generated overall revenue worth above EUR1 billion, up 10% against 2012, amid the rising number of units. more
-
Former Pharma Manager Sets Up Ecofarmacia Network
09.01.2014
Marius Chereches, former manager of companies such as Ozone or PharmaFarm, has in the past four years developed Ecofarmacia pharmacy network, which has reached 26 units in Ardeal area of Romania. more
-
Pfizer To Invest Further In Romania Plant
07.17.2014
Pfizer will continue to invest in the medium-sized production facility it owns in Cluj, northwestern Romania, according to Nolan Townsend, the American who arrived in Romania in May to take over the more
-
Analysts: Tough Times Await Pharmaceutical Companies
05.28.2014
The year 2013 brought a surprise change at the peak of the Romanian drug industry, with Switzerland’s Roche gaining the top spot amid the largest players on the local profile market, after reaching more
-
New Terapia Owner Sees Tremendous Growth Opportunities In Romania
04.15.2014
Sun Pharmaceutical, the Indian company that took over Ranbaxy, owner of Terapia plant, Romania’s largest drug maker, sees “tremendous” growth potential in Romania in the coming period, when the more
-
A&D Pharma Group Turnover Topped EUR1B In 2013
04.01.2014
Pharmaceutical group A&D Pharma had a turnover of RON4.7 billion (EUR1.07 billion) in 2013, up 6.7% on the year, as its distribution division Mediplus and Sensiblu drugstores had higher sales and the more
-
Four Pharma Managers Set Up Drug Marketing Company
02.25.2014
Alin Iosep, Dan Nicolescu, Octavian Iacob and Dragos Popescu, entrepreneurs or managers with experience on the pharmaceutical market, have set up Pharmalink, a marketing and sales business targeting more
-
A&D Pharma, Constantly Mulled By Foreign Investors
02.12.2014
A&D Pharma is constantly eyed by foreign investors, as the largest group in the Romanian pharmaceutical industry was seen for years an investment target for major companies wanting to tap the domestic more
-
Bayer Is Optimistic About Romania’s Economic Growth
12.05.2013
German conglomerate Bayer is optimistic about Romania, as the country is expected to see annual economic growth of 3% to 4% by 2018, said Andreas Schremmer, managing director of Bayer Romania. more
-
IMS Health: Romanian Pharmaceutical Market Rose 6% To RON9.3B In January-September
12.02.2013
The Romanian pharmaceutical market rose 6% in the first nine months of 2013 to 9.33 billion lei (EUR2.11 billion), according to market research company IMS Health. more
-
A&D Pharma Head: This Year’s Objective Was To Make Sensiblu Drugstores Profitable
11.28.2013
Romania’s largest pharmaceutical group A&D Pharma targeted this year to make the Sensiblu drugstore network profitable, after it was affected by a “very aggressive competition on the market”, more
-
A&D Pharma Head: Mediplus Turnover To Rise 10% In 2013; Sensiblu Will Still See Loss
10.22.2013
The turnover of Romanian medical drug distributor Mediplus, part of pharmaceutical group A&D Pharma, will increase over 10% this year, Robert Popescu, the group’s general manager, told Mediafax more
-
Stephen Stead Returns To Pharmaceutical Market As Ranbaxy Regional Director
10.22.2013
British-born Stephen Stead, who in August 2012 stepped down as CEO of Labormed, has returned to the pharmaceutical industry in a regional position within Ranbaxy and is based in Romania. He is more
-
Alvogen Aims For 15% Growth In 2014
10.02.2013
Alvogen and Labormed Pharma, which the former bought last December, will post 265 million lei (EUR60 million) revenue in 2013, says Laurentiu Scheusan, Alvogen’s executive vice-president in Central more